Skip to content

Electrofulguration- A novel technique in recipient site preparation in vitiligo surgery.

A comparative study between recipient site preparation using manual dermabrasion and electrofulguration assisted dermabrasion in autologous non cultured epidermal cell suspension procedure in stable vitiligo patients and correlation of growth factors in the cell suspension with clinical response

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/01/022671
Enrollment
30
Registered
2020-01-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Electrofulguration assisted dermabrasion: Electrofulguration of the patch will be done using hyfrecator at monoterminaland low output mode using the ball tipped electrode bent at 30 deg

Sponsors

Department of Dermatology Venereology and Leprology PGIMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinical diagnosis of segmental or non segmental vitiligo 2 independent patchesbof 3x 3 cm size each present symmetrically or unilaterally over the same part or a single patch ofvsize 6x6 cm Stable leaions for more than 1 year Disease is not responding to medical therapy for 12 weeks or residual patches post medical therapy

Exclusion criteria

Exclusion criteria: Pregnancy and lactation History of unstable cardiac diseasevor pacemakers Patients with active disease VIDA more than 1 History of hypertrophic scars or keloid Skin infection Patients with unrealistic expectations History of bleeding disorders Patients on anticoagulants Immunosuppressed patients Patients still in wash off period of therapy that is 4 weeks for topical and 12 weeks for systemic therapy

Design outcomes

Primary

MeasureTime frame
To assess the percentage of patients achieving 75 percent repigmentation with respect to the two different methods at 24 weeks of follow up post treatmentTimepoint: 0 4 8 12 16 24 weeks

Secondary

MeasureTime frame
To assess whether the extent of repigmentation has any correlation to the expression levels of growth factors which are SCF, bFGF, endothelin 1Timepoint: 0 4 8 12 16 24 weeks;To evaluate the repigmentation patterns of the lesions pre and post post procedure by dermoscopy and to ennumerate the dermatoscopic markers of repigmentation as well markers of success of the procedureTimepoint: 0 4 8 12 16 24 weeks

Countries

India

Contacts

Public ContactAnubha Dev

Department of Dermatology, PGIMER, Chandigarh

vinay.keshavmurthy@gmail.com8754841807

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026